GENE ONLINE|News &
Opinion
Blog

Transforming Healthcare Ecosystems with Artificial Intelligence

by GeneOnline
Share To

Two sessions over two days devoted entirely to AI

Artificial Intelligence (AI) is the new buzzword in biomedicine, and for good reason. With the potential to drastically reduce the time and cost burdens of drug development, the biggest names in Big Pharma are already utilizing this powerful tool. AI is increasingly important in today’s ‘smart’ healthcare settings; assisting in hospital admission triage and patient management, ‘viewing’ and analyze medial images to detect breast and other cancers, and identifying disease biomarkers for conditions such as Alzheimer’s. A vital tool in the pandemic era, AI has proven its worth in time-critical case tracking assignments and other epidemiological tasks.

A reflection of its importance, BIO Asia–Taiwan 2020 has dedicated two sessions over two days entirely to AI, with a twelve international speakers presenting the latest advances, case studies and future application scenarios for this exciting new technology.

Don’t miss Leo Anthony Celi, Principal Research Scientist, Massachusetts Institute of Technology, with his presentation ‘Battling the Pandemic with Open Science and Cross-Disciplinary Collaboration’; Faisal Khan of AstraZeneca with his talk ‘How to Apply AI to Different Stages of Drug Development’; and Joris Van Dam and Stephane Wolf of Novartis with his presentation ‘Why and How Pharma Use AI in Digital Therapeutics Platform’. Catch these and more AI-focused presentations and panel discussions at Sessions 7 and 14, BIO Asia–Taiwan 2020.

 

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
M&A
Health Innovations Acquires a Singapore-based Startup, Strengthening Digital Healthcare
2023-09-11
Charting the Future of Healthcare: Unveiling the Healthcare Industry Transformation Map 2025
2023-08-14
BIO Asia-Taiwan 2023: Crossing Borders, Establishing a Global Biotech Ecosystem
2023-08-10
LATEST
Ginkgo Bioworks and Pfizer Forge $331 Million Collaboration for RNA-Based Drug Discovery
2023-09-29
Johnson & Johnson Partners with Singapore to Boost Life Sciences Innovation
2023-09-28
Vietnam and South Korea Strengthen Cooperation in Multiple Sectors
2023-09-27
PeptiDream and Genentech Collaborate on Novel Peptide-Radioisotope Drug Conjugates
2023-09-27
AcuraStem and Takeda Collaborate on Innovative ALS Treatment
2023-09-27
Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report
2023-09-27
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
EVENT
2023-10-04
BioFuture 2023
New York city,USA
Scroll to Top